One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing
doi : 10.1093/eurheartj/ehae197
Volume 45, Issue 14, 7 April 2024
Engaging with patients and families: hearing their voice and translating the evidence
The ‘10 commandments’ for the 2023 ESC Guidelines for the management of acute coronary syndromes
Plasma proteins can tell your biological organs’ age (including the heart)
The year in cardiovascular medicine 2023: the top 10 papers in interventional cardiology
The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart disease
The year in cardiovascular medicine 2023: the top 10 papers in diabetes and metabolic disorders
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry
Implantable loop recorders in patients with Brugada syndrome: the BruLoop study
Can an implantable loop recorder improve risk stratification and appropriate management in Brugada syndrome?
Cardiac implantable electronic devices and bloodstream infections: management and outcomes
Blood stream infection in defibrillator recipients: cardiac imaging for all patients or sometimes skillful neglect?
Comparative effectiveness research using claims data: meticulous methods don’t solve old problems
Successful percutaneous treatment of perinatal complete left coronary thrombotic occlusion
A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails
Correction to: Conventional heart failure therapy in cardiac ATTR amyloidosis
